B4GALT1
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
B4GALT1; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1; GGTB2; beta-1,4-galactosyltransferase 1; beta4Gal T1; lactose synthase; beta-1,4-GalTase 1; glycoprotein-4-beta-galactosyltransferase 2; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltra;
BTK
Bruton agammaglobulinemia tyrosine kinase
BTK; Bruton agammaglobulinemia tyrosine kinase; AGMX1, IMD1; tyrosine-protein kinase BTK; ATK; PSCTK1; XLA; B-cell progenitor kinase; agammaglobulinaemia tyrosine kinase; tyrosine-protein kinase BTK isoform (lacking exon 14); dominant-negative kinase-defi;
HPGD
hydroxyprostaglandin dehydrogenase 15-(NAD)
HPGD; hydroxyprostaglandin dehydrogenase 15-(NAD); 15-hydroxyprostaglandin dehydrogenase [NAD(+)]; SDR36C1; short chain dehydrogenase/reductase family 36C; member 1; prostaglandin dehydrogenase 1; NAD+-dependent 15-hydroxyprostaglandin dehydrogenase; shor;
PTGDS
prostaglandin D2 synthase 21kDa (brain)
PTGDS; prostaglandin D2 synthase 21kDa (brain); prostaglandin D2 synthase (21kD, brain); prostaglandin-H2 D-isomerase; L PGDS; lipocalin type prostaglandin D synthase; PGDS; cerebrin-28; PGD2 synthase; beta-trace protein; prostaglandin D synthase; prostaglandin-D2 synthase; glutathione-independent PGD synthase; glutathione-independent PGD synthetase; lipocalin-type prostaglandin D synthase; lipocalin-type prostaglandin-D synthase; PDS; PGD2; LPGDS; PGDS2; L-PGDS;
PTGES
prostaglandin E synthase
PTGES; prostaglandin E synthase; MGST1L1; glutathione S transferase 1 like 1; MGST IV; MGST1 L1; MGST1 like 1; microsomal glutathione S transferase 1 like 1; microsomal prostaglandin E synthase 1; p53 induced gene 12; PIG12; TP53I12; tumor protein p53 ind;
PTGES2
prostaglandin E synthase 2
PTGES2; prostaglandin E synthase 2; C9orf15, chromosome 9 open reading frame 15; FLJ14038; C9orf15; Gamma interferon activated transcriptional element binding factor 1; GATE binding factor 1; GBF1; Membrane associated prostaglandin E synthase 2; MGC11289; Microsomal prostaglandin E synthase 2; mPGES 2; mPGES-2; PGES2; PGES2_HUMAN; Prostaglandin E synthase 2 truncated form; PTGES 2; OTTHUMP00000022231; OTTHUMP00000022232; OTTHUMP00000215363; GATE-binding factor 1; microsomal prostaglandin E synthase-2; membrane-associated prostaglandin E synthase 2; gamma-interferon-activated;
PTGES3
prostaglandin E synthase 3 (cytosolic)
PTGES3; prostaglandin E synthase 3 (cytosolic); prostaglandin E synthase 3; cPGES; p23; TEBP; Hsp90 co-chaperone; telomerase-binding protein p23; progesterone receptor complex p23; cytosolic prostaglandin E synthase; cytosolic prostaglandin E2 synthase; u;
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
Ptgs2; prostaglandin-endoperoxide synthase 2; COX2; Cox-2; PHS-2; Pghs2; TIS10; PGHS-2; PES-2; PHS II; gripghs; PGH synthase 2; cyclooxygenase 2; cyclooxygenase-2; prostaglandin H2 synthase 2; glucocorticoid-regulated inflammatory cyclooxygenase; macrophage activation-associated marker protein P71/73; prostaglandin G/H synthase, Tis10;
B4GALT4
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4
B4GALT4; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4; beta-1,4-galactosyltransferase 4; beta4Gal T4; B4Gal T4; Beta 1 4 galactosyltransferase 4; Beta 1 4 GalTase 4; Beta N acetylglucosaminyl glycolipid beta 1 4 galactosyltransferase 4; EC 2.4.1.-; UDP Gal:betaGlcNAc beta,4 galactosyltransferase 4; UDP Gal:betaGlcNAc beta 1 4 galactosyltransferase polypeptide 4; UDP galactose:beta N acetylglucosamine beta 1 4 galactosyltransferase 4; beta-1,4-GalTase 4; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase 4; beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase 4; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4; B4Gal-T4; beta4Gal-T4;
PTGIR
prostaglandin I2 (prostacyclin) receptor (IP)
PTGIR; prostaglandin I2 (prostacyclin) receptor (IP); prostacyclin receptor; IP; PGI receptor; PGI2 receptor; prostanoid IP receptor; prostaglandin I2 receptor; PRIPR; MGC102830;
B4GALT5
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5
B4GALT5; UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5; beta-1,4-galactosyltransferase 5; 4-galactosyltransferase 5; 4-GalT II; 4-GalTase 5; B4Gal T5; b4Gal-T5; B4GT5_HUMAN; Beta 1 4 galactosyltransferase 5; Beta 1 4 galactosyltransferase V; Beta 1 4 GalT II; Beta 1 4 GalT IV; Beta 1 4 GalTase 5; Beta-1; Beta4 GALT IV; Beta4Gal T5; Beta4Gal-T5; Beta4GalT V; gt V; gtV; MGC138470; UDP Gal:beta GlcNAc beta 1 4 galactosyltransferase 5; UDP Gal:betaGlcNAc beta 1 4galactosyltransferase 5; UDP Gal:betaGlcNAc beta 1 4 galactosyltransferase polypeptide 5; UDP galactose:beta N acetylglucosamine beta 1 4 galactosyltransferase 5; UDP-Gal:beta-GlcNAc beta-1; UDP-galactose:beta-N-acetylglucosamine beta-1; beta-1,4-GalT II; OTTMUSP00000001139; beta-1,4-GalTase 5; beta-1,4-galactosyltransferase V; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltr; AW049941; AW539721; 9430078I07Rik;
PTGIS
prostaglandin I2 (prostacyclin) synthase
PTGIS; prostaglandin I2 (prostacyclin) synthase; prostacyclin synthase; Cyp8; Pgis; Cyp8a1;
B4GALT3
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3
B4GALT3; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3; beta-1,4-galactosyltransferase 3; beta4Gal T3; b4Gal T3; Beta 1,4 galactosyltransferase 3; Beta 1,4 GalTase 3; UDP Gal:beta GlcNAc beta-1,4 galactosyltransferase 3; b4Gal-T3; OTTHUMP00000032247; OTTHUMP00000032248; beta-1,4-GalTase 3; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3; beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase 3; UDP-galactose:beta-N-acetylglucos; beta4Gal-T3;
PTGER3
prostaglandin E receptor 3 (subtype EP3)
PTGER3; prostaglandin E receptor 3 (subtype EP3); prostaglandin E2 receptor EP3 subtype; EP3; prostanoid EP3 receptor; PGE receptor, EP3 subtype; PGE2 receptor EP3 subtype; prostaglandin receptor (PGE-2); prostaglandin E receotor EP3 subtype 3 isoform; EP;
PTGS1
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
PTGS1; prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase); COX1; COX3; PHS1; PCOX1; PES-1; PGHS1; PTGHS; PGG/HS; PGHS-1; prostaglandin G/H synthase 1; PGH synthase 1; cyclooxygenase-1; prostaglandin H2 synthase 1;
PTGER2
prostaglandin E receptor 2 (subtype EP2), 53kDa
PTGER2; prostaglandin E receptor 2 (subtype EP2), 53kDa; prostaglandin E receptor 2 (subtype EP2), 53kD; prostaglandin E2 receptor EP2 subtype; EP2; prostanoid EP2 receptor; PGE receptor EP2 subtype; PGE2 receptor EP2 subtype;
HPGDS
hematopoietic prostaglandin D synthase
HPGDS; hematopoietic prostaglandin D synthase; glutathione S transferase sigma; GSTS; H PGDS; PGDS; GST class-sigma; prostaglandin-H2 D-isomerase; glutathione S-transferase sigma; glutathione-dependent PGD synthase; glutathione-dependent PGD synthetase; h;
PTGDR
prostaglandin D2 receptor (DP)
PTGDR; prostaglandin D2 receptor (DP); prostaglandin D2 receptor; DP; DP1; PTGDR1; AS 1; AS1; ASRT 1; ASRT1; MGC49004; OTTHUMP00000178986; PD2R_HUMAN; PGD receptor; PGD2 receptor; Prostanoid DP receptor;
AGL
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
AGL; amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase; amylo 1, 6 glucosidase, 4 alpha glucanotransferase; glycogen debranching enzyme; glycogen storage disease type III; 9430004C13Rik; 9630046L06Rik; AI850929; C77197; 1110061O17Rik; Amylo 1 6 glucosidase 4 alpha glucanotransferase; GDE; Glycogen debrancher; amylo-1, 6-glucosidase, 4-alpha-glucanotransferase;
B4GALT6
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6
B4GALT6; UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6; beta-1,4-galactosyltransferase 6; 4-galactosyltransferase 6; 4-galactosyltransferase; 4-GalTase 6; AA536803; AU022389; b4Gal-T6; B4GT6_HUMAN; Beta-1; Beta4Gal-T6; LacCer synthase; Lactosylceramide synthase; UDP-Gal:beta-GlcNAc beta-1; UDP-Gal:glucosylceramide beta-1; UDP-galactose:beta-N-acetylglucosamine beta-1; beta-1,4-GalTase 6; beta-1, 4-galactosyltransferase VI; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6; UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6;
B4GALT2
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2
B4GALT2; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2; beta-1,4-galactosyltransferase 2; beta4Gal T2; Beta 1,4 galactosyltransferase 2; B4Gal T2; Beta 1,4 GalTase 2; Beta 4 GalT2; Beta N acetylglucosaminyl glycolipid beta 1,4 galactosyltransferase 2; UDP Gal:beta GlcNAc beta 1,4 galactosyltransferase 2; UDP Gal:betaGlcNAc beta 1,4 galactosyltransferase polypeptide 2; UDP galactose:beta N acetylglucosamine beta 1,4 galactosyltransferase 2; beta-4-GalT2; beta-1,4-GalTase 2; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 2; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase 2; UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 2; beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase 2; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2; B4Gal-T2; B4Gal-T3; beta4Gal-T2;
GGH
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
GGH; gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase); gamma-glutamyl hydrolase; gamma-Glu-X carboxypeptidase; GH;
PTGDR2
prostaglandin D2 receptor 2
PTGDR2; prostaglandin D2 receptor 2; G protein coupled receptor 44 , GPR44; putative G-protein coupled receptor 44; CD294; chemoattractant receptor homologous molecule expressed on T helper type 2 cells; CRTH2; DP2; CD294 antigen; Chemoattractant receptor homologous molecule expressed on Th2 cells; Chemoattractant receptor-homologous molecule expressed on Th2 cells; CRTH 2; DL1R; G Protein Coupled Receptor 44; GPR 44; Gpr44; GPR44_HUMAN; Putative G protein coupled receptor 44; G protein-coupled receptor 44;
IBTK
inhibitor of Bruton agammaglobulinemia tyrosine kinase
IBTK; inhibitor of Bruton agammaglobulinemia tyrosine kinase; Bruton agammaglobulinemia tyrosine kinase inhibitor , BTKI; inhibitor of Bruton tyrosine kinase; DKFZP564B116; BTK-binding protein; inhibitor of Brutons tyrosine kinase; inhibitor of Brutons ty;
PTGER4
prostaglandin E receptor 4 (subtype EP4)
PTGER4; prostaglandin E receptor 4 (subtype EP4); EP4; EP4R; prostaglandin E2 receptor EP4 subtype; prostanoid EP4 receptor; PGE receptor EP4 subtype; PGE receptor, EP4 subtype; PGE2 receptor EP4 subtype;
PTGER1
prostaglandin E receptor 1 (subtype EP1), 42kDa
PTGER1; prostaglandin E receptor 1 (subtype EP1), 42kDa; prostaglandin E receptor 1 (subtype EP1), 42kD; prostaglandin E2 receptor EP1 subtype; EP1; PGE receptor EP1 subtype; PGE2 receptor EP1 subtype; Prostaglandin E receptor 1 subtype EP1 42kDa; Prostaglandin E receptor 1 subtype EP1; Prostanoid EP1 receptor; PGE receptor, EP1 subtype; prostaglandin E receptor 1, subtype EP1;
PTGR1
prostaglandin reductase 1
PTGR1; prostaglandin reductase 1; leukotriene B4 12 hydroxydehydrogenase , LTB4DH; ZADH3; zinc binding alcohol dehydrogenase domain containing 3; PRG-1; 15-oxoprostaglandin 13-reductase; leukotriene B4 12-hydroxydehydrogenase; NADP-dependent leukotriene B;
PTGR2
prostaglandin reductase 2
PTGR2; prostaglandin reductase 2; ZADH1, zinc binding alcohol dehydrogenase domain containing 1; FLJ39091; 15 oxoprostaglandin 13 reductase; 15 oxoprostaglandin delta 13 reductase; DKFZp686P10120; FLJ99229; PGR 2; PGR2; PTGR 2; Zinc binding alcohol dehydrogenase domain containing 1; Zinc binding alcohol dehydrogenase domain containing protein 1; PRG-2; 15-oxoprostaglandin 13-reductase; 15-oxoprostaglandin-delta13-reductase; zinc binding alcohol dehydrogenase, domain containing 1; zinc-binding alcohol dehydrogenase domain-containing protein 1; ZADH1;
B3galt5
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5
B3GALT5;UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5;ENSMUSG00000074892;AU045265;b3Galt-V;1190002B21Rik;16 C4;16;beta-1,3-galactosyltransferase 5;beta-1,3-galactosyltransferase 5;b3Gal-T5;beta3GalT5;beta3Gal-T5;beta-3-Gx-T5;SSEA-3 synthase;beta-1,3-GalTase 5;stage-specific embryonic antigen 3 synthase;UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5;UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5;EC 2.4.1.-;
PTGFRN
prostaglandin F2 receptor negative regulator
PTGFRN;prostaglandin F2 receptor negative regulator;9601;ENSG00000134247;FPRP;CD315;EWI-F;CD9P-1;SMAP-6;1p13.1;FLJ11001, KIAA1436;prostaglandin F2 receptor negative regulator;prostaglandin F2 receptor negative regulator;CD9 partner 1;glu-Trp-Ile EWI motif-containing protein F;prostaglandin F2-alpha receptor regulatory protein;prostaglandin F2-alpha receptor-associated protein;
PTGFR
prostaglandin F receptor (FP)
PTGFR;prostaglandin F receptor (FP);9600;ENSG00000122420;FP;1p31.1;MGC46203, MGC120498;prostaglandin F2-alpha receptor;prostaglandin F2-alpha receptor;PGF receptor;PGF2 alpha receptor;PGF2-alpha receptor;prostanoid FP receptor;prostaglandin F2 alpha receptor;prostaglandin receptor (2-alpha);
